Latest filing published 06 Oct 2026 for ImmunityBio, Inc., €239k.
Barry J. Simon is a declared insider of ImmunityBio, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 5 May 2021 to 5 October 2026.
The open-market record consists of 6 sales worth €1.9M, with no purchase. Outside the open market, there are 5 option exercises. In 2026 alone, the filings show no purchases and 5 sales.
The record was last updated on 6 October 2026 with an open-market sale (€239k) in ImmunityBio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations